Most Scottish health boards don't offer Wegovy or Mounjaro for weight loss, and the few that do run small pilots. The Royal College of Physicians president calls it discriminatory.
Recap by typeshit. Full story at BBC.
8:09
Regan Archibald gives his take on the timeline for retatrutide reaching patients. Tap through for his view on where the drug stands.
Morse says bar and restaurant workers have seen younger adults drink less, framing it as a broad change in the alcohol industry.
Bazaar India's new issue looks at collagen loss and skin laxity concerns tied to fast GLP-1 weight loss, and how beauty brands are responding.
Novo also reported 25% average weight loss in women on CagriSema in a post-hoc trial analysis, while BMO flagged Ozempic losing US share.
Inspectors in Chengdu reported black mold, insects and staff allegedly hiding records. Ainvest looks at what it means for Novo, Lilly and Hims & Hers.
Reported effects of the gray-market triple agonist range from gut problems to burning skin, panic attacks and depression.
Loading…